Diabetes is a growing public health crisis in Pakistan, with over 33 million adults affected as of 2021. Among the various treatment options, insulin therapy is crucial for managing type 1 diabetes (T1D) and advanced type 2 diabetes (T2D). However, a significant issue known as “insulin denial” has emerged, where patients resist or refuse insulin therapy despite medical indications. This phenomenon is driven by psychological factors, such as fear and stigma; socio-cultural beliefs that associate insulin with severe complications; and healthcare-related challenges, including inadequate access and support. The consequences of insulin denial can be severe, leading to uncontrolled diabetes and life-threatening complications, which also place an economic burden on individuals and the healthcare system. To address this issue, a multifaceted approach is essential, including public awareness campaigns, enhanced healthcare provider training, improved access to insulin, and psychosocial support for patients. By tackling insulin denial, Pakistan can enhance diabetes management and improve patient outcomes.

Insulin, Pakistan, Diabetes, Denial, Complications, Psychological, Socio-cultural, Healthcare.

Diabetes is a chronic, debilitating condition that affects millions of people globally. In Pakistan, the burden of diabetes is escalating at an alarming rate. According to the International Diabetes Federation (IDF), over 33 million adults in Pakistan were living with diabetes in 2021, making it the third-highest prevalence rate globally for the disease.[1] Among these individuals, insulin therapy plays a crucial role, especially for those with T1D and advanced T2D. However, an alarming issue has emerged in Pakistan — the denial or avoidance of insulin therapy by patients, commonly referred to as “insulin denial.”

The Problem of insulin denial
Insulin denial refers to the resistance or refusal of patients to start or continue insulin therapy, despite medical indications. This phenomenon is widespread in Pakistan and poses a significant threat to the effective management of diabetes. There are several underlying reasons for this denial, which can be categorized into psychological, socio-cultural, and healthcare-related factors.

Psychological factors
One of the major barriers to insulin acceptance in Pakistan is the fear and stigma associated with insulin injections. Many patients perceive insulin initiation as an indicator that their diabetes has worsened, leading to psychological distress.[2] Moreover, needle phobia is a considerable issue. Research has shown that many individuals, particularly in low- and middle-income countries like Pakistan, experience anxiety related to self-injecting insulin, which contributes to their reluctance to start therapy.[3]

Socio-cultural factors
Socio-cultural beliefs play a vital role in insulin denial. In many parts of Pakistan, insulin is perceived as a treatment of last resort, and patients tend to associate it with severe complications or impending death. Furthermore, some cultural misconceptions suggest that insulin may cause blindness or infertility, further deterring patients from accepting the treatment.[4] Such misconceptions are compounded by the lack of awareness about diabetes management in rural and underserved areas of the country.

The family unit, which holds great importance in Pakistani society, also influences the decision to initiate insulin therapy. Patients may avoid insulin because they fear becoming a burden on their families, particularly in cases where family members are responsible for administering the injections.[5]

Healthcare-related factors
Healthcare-related factors also contribute to insulin denial. The healthcare system in Pakistan is often underfunded, understaffed, and lacks adequate infrastructure, particularly in rural areas. Access to insulin is not always guaranteed, and inconsistent supply chains make it challenging for patients to obtain their medications on a regular basis.[6] Furthermore, the cost of insulin can be prohibitive for many patients. While insulin may be available for free or at a subsidized cost in public hospitals, the expenses related to transport, syringes, and glucometers pose additional financial burdens.[7]

Healthcare providers may also play a role in insulin denial. Inadequate counseling and insufficient time spent with patients have been identified as barriers to proper diabetes management.[8] In many cases, healthcare professionals may not emphasize the importance of insulin therapy or may fail to address the patients’ concerns about insulin, further contributing to their resistance.

Consequences of insulin denial
The consequences of insulin denial in Pakistan are dire. Uncontrolled diabetes due to delayed or absent insulin therapy can lead to devastating complications, including diabetic ketoacidosis, nephropathy, retinopathy, neuropathy, and cardiovascular disease.[9] In particular, patients with T1D who are dependent on insulin face life-threatening consequences if they do not receive timely treatment.

The economic burden associated with complications arising from poorly managed diabetes is substantial. It not only affects individual households but also strains the already overburdened healthcare system in Pakistan. A study reported that complications of diabetes lead to increased hospital admissions and long-term healthcare costs.[10]

Addressing the issue
Addressing insulin denial requires a multi-faceted approach. First, public awareness campaigns must be launched to educate the general population about diabetes, its management, and the safety and importance of insulin therapy. Dispelling myths and misconceptions surrounding insulin is critical in changing public perceptions.

Second, healthcare providers need to be trained to provide comprehensive diabetes education and counseling. Emphasis should be placed on creating patient-centered care plans that involve detailed discussions about insulin therapy, addressing patients’ fears, and ensuring they understand the long-term benefits of managing their diabetes effectively.[11]

Third, improving access to insulin in rural and underserved areas is essential. The government and non-governmental organizations (NGOs) should collaborate to ensure the continuous supply of insulin and other diabetes-related supplies. Additionally, reducing the financial burden on patients by subsidizing the cost of insulin, glucometers, and syringes can improve adherence to treatment.[12]

Finally, psychosocial support services should be made available to patients with diabetes. Counseling and peer support groups can help patients overcome their fears and anxieties about insulin therapy. Mental health support for patients struggling with the emotional impact of their diagnosis and treatment is also critical in overcoming insulin denial.[13]

Insulin denial is a serious public health concern in Pakistan that requires immediate attention. The rising prevalence of diabetes, coupled with widespread misconceptions, inadequate healthcare infrastructure, and financial barriers, has made this issue even more pressing. A concerted effort from healthcare providers, policymakers, and the community at large is necessary to address this challenge. By promoting insulin acceptance through education, improving access to healthcare, and providing psychological support, Pakistan can mitigate the impact of insulin denial and improve the outcomes for people living with diabetes.

Not reported

None

Asim Abid Minhas
Department of Medicine
Dow Medical College, Pakistan
Email: asimabidminhas@outlook.com

The author contributed to the conceptualization, investigation, and data curation by acquiring and critically reviewing the selected articles and was involved in the writing – original draft preparation and writing – review & editing to refine the manuscript. 

Not applicable

https://doi.org/10.63096/medtigo30622473

Asim AM. The Impact of Doctor Shopping on Healthcare in Pakistan: Challenges and Solutions. medtigo J Med. 2024;2(4):e30622473. doi:10.63096/medtigo30622473 Crossref